Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosis

Am J Respir Crit Care Med. 2006 Jan 1;173(1):130; author reply 130-1. doi: 10.1164/ajrccm.173.1.130.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Humans
  • Immunoassay / methods*
  • Immunocompromised Host / immunology*
  • Interferon-gamma / immunology*
  • Sensitivity and Specificity
  • Tuberculin Test
  • Tuberculosis / diagnosis*
  • Tuberculosis / immunology*

Substances

  • Interferon-gamma